1. Home
  2. EGY vs ACHV Comparison

EGY vs ACHV Comparison

Compare EGY & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VAALCO Energy Inc.

EGY

VAALCO Energy Inc.

HOLD

Current Price

$5.44

Market Cap

561.8M

Sector

Energy

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$6.49

Market Cap

618.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EGY
ACHV
Founded
1985
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.8M
618.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
EGY
ACHV
Price
$5.44
$6.49
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.30
$14.67
AVG Volume (30 Days)
1.5M
2.7M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
3.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$359,272,000.00
N/A
Revenue This Year
$8.78
N/A
Revenue Next Year
$29.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.36
$2.38
52 Week High
$6.72
$7.11

Technical Indicators

Market Signals
Indicator
EGY
ACHV
Relative Strength Index (RSI) 54.24 60.23
Support Level $5.04 $4.09
Resistance Level $5.58 $7.11
Average True Range (ATR) 0.19 0.44
MACD 0.04 -0.03
Stochastic Oscillator 84.17 53.70

Price Performance

Historical Comparison
EGY
ACHV

About EGY VAALCO Energy Inc.

VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: